| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |